A non-rebreathing mask is not suitable for long-term oxygen therapy.
The non-rebreathing mask is designed for short-term, high-concentration oxygen administration in emergency or acute care settings. It delivers a high FiO₂ ranging from 60% to 80% at 10–15 L/min flow. Sustained use of such high oxygen levels over days or weeks carries significant risks, including oxygen toxicity, absorption atelectasis, and carbon dioxide retention, especially for patients with chronic respiratory conditions like COPD.
Besides safety concerns, non breathing mask is uncomfortable for prolonged wear. The tight mask seal causes facial pressure, skin breakdown, dry nasal and oral mucosa, and difficulty eating, drinking or speaking. Its reservoir bag and valve structure also make it bulky and impractical for daily home use.
For stable patients requiring long-term oxygen, clinicians prefer low-flow systems such as nasal cannulae or venturi masks. These deliver controlled, lower oxygen concentrations continuously, with better comfort and lower complication rates. Non-rebreathing masks are reserved only for acute hypoxemia until the patient stabilises and switches to a proper long-term oxygen device.